日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer Growth

共价变构分子胶抑制NRF2依赖性癌症生长

Roy, Nilotpal; Wyseure, Tine; Lo, I-Chung; Lu, Justine; Eissler, Christie L; Bernard, Steffen M; Bok, Ilah; Snead, Aaron N; Parker, Albert; Lo, U-Ging; Green, Jason C; Inloes, Jordon; Jacinto, Sarah R; Kuenzi, Brent; Pariollaud, Marie; Negri, Kathleen; Le, Khoi; Horning, Benjamin D; Ibrahim, Noah; Grabow, Stephanie; Panda, Harit; Bhatt, Dhaval P; Wilkerson, Emily M; Saeidi, Soma; Zolkind, Paul; Rush, Zoe; Williams, Heather N; Walton, Eric; Pastuszka, Martha K; Sigler, John J; Tran, Eileen; Hee, Kenneth; McLaughlin, Joseph; Ambrus-Aikelin, Géza; Pollock, Jonathan; Abraham, Robert T; Kinsella, Todd M; Simon, Gabriel M; Major, Michael B; Weinstein, David S; Patricelli, Matthew P

Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.

放化疗可重编程宫颈癌的肿瘤细胞和免疫微环境。

Sandoval Tito A, Li Yize, Muhammad Naoshad, Desai Tresha, Jayasinghe Reyka G, Zeeshan Saman, Jayachandran Kay, Inkman Matthew J, Waters Michael R, Msengi Eliwaza Naomi S, McKinnish Tyler R, Hatipoglu Ibrahim, Paschoalini Mafra Ana Carolina, Anwar Muyassar, Hu Donghua, Bhatt Dhaval P, Lander Varintra E, Mashl R Jay, Houston Andrew, Chen Liyun, Contreras Jessika, Robinson Clifford G, Davies Sherri R, Belmar Julie, Li Shunqiang, Major Michael B, DeNardo David G, Markovina Stephanie, Edelson Brian T, Zhang Jin, Ding Li, Schwarz Julie K

The contribution of de novo coding mutations to meningomyelocele

新发编码突变对脊髓脊膜膨出的影响

Ha, Yoo-Jin Jiny; Nisal, Ashna; Tang, Isaac; Lee, Chanjae; Jhamb, Ishani; Wallace, Cassidy; Howarth, Robyn; Schroeder, Sarah; Vong, Keng Ioi; Meave, Naomi; Jiwani, Fiza; Barrows, Chelsea; Lee, Sangmoon; Jiang, Nan; Patel, Arzoo; Bagga, Krisha; Banka, Niyati; Friedman, Liana; Blanco, Francisco A; Yu, Seyoung; Rhee, Soeun; Jeong, Hui Su; Plutzer, Isaac; Major, Michael B; Benoit, Béatrice; Poüs, Christian; Heffner, Caleb; Kibar, Zoha; Bot, Gyang Markus; Northrup, Hope; Au, Kit Sing; Strain, Madison; Ashley-Koch, Allison E; Finnell, Richard H; Le, Joan T; Meltzer, Hal S; Araujo, Camila; Machado, Helio R; Stevenson, Roger E; Yurrita, Anna; Mumtaz, Sara; Ahmed, Awais; Khara, Mulazim Hussain; Mutchinick, Osvaldo M; Medina-Bereciartu, José Ramón; Hildebrandt, Friedhelm; Melikishvili, Gia; Marwan, Ahmed I; Capra, Valeria; Noureldeen, Mahmoud M; Salem, Aida M S; Issa, Mahmoud Y; Zaki, Maha S; Xu, Libin; Lee, Ji Eun; Shin, Donghyuk; Alkelai, Anna; Shuldiner, Alan R; Kingsmore, Stephen F; Murray, Stephen A; Gee, Heon Yung; Miller, W Todd; Tolias, Kimberley F; Wallingford, John B; Kim, Sangwoo; Gleeson, Joseph G

A SETD2-CDK1-lamin axis maintains nuclear morphology and genome stability.

SETD2-CDK1-核纤层蛋白轴维持细胞核形态和基因组稳定性。

Khan Abid, Zhang Cheng, Nguyen Phu G, Metts James M, Collins Lucas C, Jain Kanishk, Mills C Allie, Vlach Logan, Li Kelin, Brademeyer Amanda L, Bowman Brittany M, Major Michael B, Aubé Jeffrey, Herring Laura E, Rathmell W Kimryn, Mason Frank M, Davis Ian J, Zhang Qing, Strahl Brian D

Stable Cas9 expression regulates cell growth by facilitating mTORC2 activation.

稳定的 Cas9 表达通过促进 mTORC2 激活来调节细胞生长。

Yu Le, Jin Yi, Chen Jianfeng, Zhu Zhichuan, Su Siyuan, Wilkerson Emily M, Gongora Joanna, Cloer Erica W, Major Michael B, Liu Pengda

Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer

NRG/RTOG 9512研究中局部区域复发与NFE2L2/KEAP1/CUL3基因突变的相关性:一项针对T2N0声门癌的放射治疗分割随机试验

Guan, Li; Torres-Saavedra, Pedro A; Zhao, Xiaobei; Major, Michael B; Holmes, Brittany J; Nguyen, Ngan K; Kumaravelu, Parasakthy; Hodge, Tim; Diehn, Maximilian; Zevallos, Jose; Holsinger, F Christopher; Emami, Bahman; Jordan, Richard C; Hayward, Michele C; Sagar, Stephen M; Morrison, William; Schultz, Christopher; Caudell, Jimmy J; Jones, Christopher U; Bratman, Scott V; Galloway, Thomas J; Ma, Daniel J; Yom, Sue S; Kudrimoti, Mahesh; Kim, Harold E; Harris, Jonathan; Le, Quynh-Thu; Hayes, D Neil

NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting

NRF2在癌症中的免疫生物学:对免疫疗法和靶向治疗的意义

Panda, Harit; Rowland, Natalie G; Krall, Caroline M; Bowman, Brittany M; Major, Michael B; Zolkind, Paul

Activating NRF2(E79Q) mutation alters the differentiation of human non-small cell lung cancer.

激活 NRF2(E79Q) 突变会改变人类非小细胞肺癌的分化。

Hamad Samera H, Joshi Hansa, Hess T, Jefferys Stuart R, Saleh Zena, Bendjilali Nasrine, Sellers Rani S, Zhu Gord, Shrank Travis, Moore Rayvon T, Corcoran David, Simon Jeremy M, Spitz Francis R, Shersher David, Major Michael B, Weissman Bernard E

Pyrimethamine and a potent analog inhibit NRF2 by suppressing one-carbon metabolism.

乙胺嘧啶及其强效类似物通过抑制一碳代谢来抑制 NRF2。

Chembo Julius, Bowman Brittany M, Lapak Kyle, Wilkerson Emily, Wamsley Nathan T, Paiboonrungruang Chorlada, Cho Kevin, Medcalf Matthew R, Wang Haining, Patti Gary J, Dolle Roland E, Chen Xiaoxin, Zolkind Paul, Major Michael B

The gain-of-function UBE3A(Q588E) variant causes Angelman-like neurodevelopmental phenotypes in mice.

UBE3A(Q588E) 功能获得性变异会导致小鼠出现类似安格曼综合征的神经发育表型

Weston Kellan P, Gunelson Anna M, Maloney Susan E, Ge Xia, Stelzer Jalin A, Kim Kwang-Soo, Collier Shylyn, Mindt Marissa M, Agajanian Megan J, Major Michael B, Goldfarb Dennis, Noguchi Kevin K, Yi Jason J